Advertisements



AbbVie announces submission of sNDA to FDA for venetoclax

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 12th, 2018

Trovagene announces preclinical data evaluating onvansertib with venetoclax

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 23rd, 2019

AbbVie announces new formulary listings for MAVIRET

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 4th, 2019

Genmab announces submission of daratumumab with bortezomib sBLA to FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 26th, 2019

Genmab announces regulatory submission for daratumumab to EMA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 22nd, 2019

AbbVie"s Venclexta Multiple Myeloma Studies Put on Hold by FDA

FDA places a partial clinical hold on all studies evaluating AbbVie's (ABBV) Venclexta (venetoclax) for the treatmen.....»»

Category: worldSource: nytMar 20th, 2019

AbbVie: FDA puts partial clinical hold on venetoclax program

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 19th, 2019

AbbVie stock down 0.8% after FDA places hold on clinical trials of venetoclax as a treatment for multiple myeloma

Shares of AbbVie Inc. fell 0.8% in premarket trade Tuesday after the Food and .....»»

Category: topSource: marketwatchMar 19th, 2019

Trevena Reports Fourth Quarter and Full Year 2018 Results

— Company announces submission of oliceridine healthy volunteer study protocol and analysis plan to FDA —  — Successful fu.....»»

Category: earningsSource: benzingaMar 13th, 2019

AbbVie: FDA grants fifth Breakthrough Therapy Designation to venetoclax

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: worldSource: nytMar 7th, 2019

Pulse Biosciences announces 510 submission to FDA for CellFX System

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 28th, 2019

FTC announces settlement with AbbVie over Solvay"s AndroGel

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 28th, 2019

Agios Pharmaceuticals announces FDA acceptance of Tibsovo sNDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 20th, 2019

AbbVie announces FDA accepted for priority review NDA for upadacitinib

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 19th, 2019

AbbVie announces FDA approval of IMBRUVICA plus obinutuzumab

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 28th, 2019

Coherus Biosciences announces CHS-1420 settlement agreements with AbbVie

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 25th, 2019

Helios and Matheson announces submission for proposed spin-off of MoviePass

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 17th, 2019

Karyopharm announces EMA submission for selinexor

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 8th, 2019

Epizyme to File NDA for Tazemetostat in Follicular Lymphoma

Epizyme (EPZM) announces that the company has identified a path to submission for accelerated approval of tazemetostat for patients with relapsed and/or .....»»

Category: dealsSource: nytJan 7th, 2019

Stemline announces submission of European MAA for ELZONRIS

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 7th, 2019

KemPharm announces FDA approval of Apadaz sNDA for two additional strengths

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 7th, 2019